Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $3.03 billion. The enterprise value is $2.23 billion.

Market Cap	3.03B
Enterprise Value	2.23B

Important Dates

The next estimated earnings date is Wednesday, October 22, 2025, after market close.

Earnings Date	Oct 22, 2025
Ex-Dividend Date	n/a

Share Statistics

VKTX has 112.44 million shares outstanding. The number of shares has increased by 7.91% in one year.

Current Share Class	112.44M
Shares Outstanding	112.44M
Shares Change (YoY)	+7.91%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	2.15%
Owned by Institutions (%)	68.74%
Float	109.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.81
P/TBV Ratio	3.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.86, with a Debt / Equity ratio of 0.00.

Current Ratio	25.86
Quick Ratio	25.26
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,217.05

Financial Efficiency

Return on equity (ROE) is -19.99% and return on invested capital (ROIC) is -15.48%.

Return on Equity (ROE)	-19.99%
Return on Assets (ROA)	-14.99%
Return on Invested Capital (ROIC)	-15.48%
Return on Capital Employed (ROCE)	-26.74%
Revenue Per Employee	n/a
Profits Per Employee	-$4.77M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.56% in the last 52 weeks. The beta is 0.72, so VKTX's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-53.56%
50-Day Moving Average	31.21
200-Day Moving Average	32.44
Relative Strength Index (RSI)	41.03
Average Volume (20 Days)	9,830,294

Short Selling Information

The latest short interest is 27.51 million, so 24.47% of the outstanding shares have been sold short.

Short Interest	27.51M
Short Previous Month	28.70M
Short % of Shares Out	24.47%
Short % of Float	25.02%
Short Ratio (days to cover)	6.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-212.84M
Pretax Income	n/a
Net Income	-171.55M
EBITDA	n/a
EBIT	-212.84M
Earnings Per Share (EPS)	-$1.54

Balance Sheet

The company has $807.72 million in cash and $878,000 in debt, giving a net cash position of $806.85 million or $7.18 per share.

Cash & Cash Equivalents	807.72M
Total Debt	878,000
Net Cash	806.85M
Net Cash Per Share	$7.18
Equity (Book Value)	795.46M
Book Value Per Share	7.08
Working Capital	795.04M

Cash Flow

Operating Cash Flow	-152.54M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.91%
Shareholder Yield	-7.91%
Earnings Yield	-5.65%
FCF Yield	n/a

Analyst Forecast

The average price target for VKTX is $86.92, which is 222.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$86.92
Price Target Difference	222.17%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1